GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ben Tre Pharmaceutical JSC (STC:DBT) » Definitions » Equity-to-Asset

Ben Tre Pharmaceutical JSC (STC:DBT) Equity-to-Asset : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Ben Tre Pharmaceutical JSC Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Ben Tre Pharmaceutical JSC's Total Stockholders Equity for the quarter that ended in . 20 was ₫0.00 Mil. Ben Tre Pharmaceutical JSC's Total Assets for the quarter that ended in . 20 was ₫0.00 Mil.

The historical rank and industry rank for Ben Tre Pharmaceutical JSC's Equity-to-Asset or its related term are showing as below:

STC:DBT's Equity-to-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.58
* Ranked among companies with meaningful Equity-to-Asset only.

Ben Tre Pharmaceutical JSC Equity-to-Asset Historical Data

The historical data trend for Ben Tre Pharmaceutical JSC's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ben Tre Pharmaceutical JSC Equity-to-Asset Chart

Ben Tre Pharmaceutical JSC Annual Data
Trend
Equity-to-Asset

Ben Tre Pharmaceutical JSC Semi-Annual Data
Equity-to-Asset

Competitive Comparison of Ben Tre Pharmaceutical JSC's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Ben Tre Pharmaceutical JSC's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ben Tre Pharmaceutical JSC's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ben Tre Pharmaceutical JSC's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Ben Tre Pharmaceutical JSC's Equity-to-Asset falls into.



Ben Tre Pharmaceutical JSC Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Ben Tre Pharmaceutical JSC's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )=Total Stockholders Equity/Total Assets
=/
=

Ben Tre Pharmaceutical JSC's Equity to Asset Ratio for the quarter that ended in . 20 is calculated as

Equity to Asset (Q: . 20 )=Total Stockholders Equity/Total Assets
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ben Tre Pharmaceutical JSC  (STC:DBT) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Ben Tre Pharmaceutical JSC Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Ben Tre Pharmaceutical JSC's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Ben Tre Pharmaceutical JSC (STC:DBT) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
6A3, 60 National Highway, Phu Tan Ward, Ben Tre Town, Ben Tre, VNM
Ben Tre Pharmaceutical JSC is engaged in producing and trading of medicine. It also imports medicine, package, materials additives, and flavoring for production. It manufactures and distributes medicament and health equipment in Ho Chi Minh, Hanoi, Danang, and Can Tho.

Ben Tre Pharmaceutical JSC (STC:DBT) Headlines

No Headlines